Ellen M. Beauchamp

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

Esra A. Akbay, Shohei Koyama, Julián Carretero et al. · Cancer Discovery · 2013 · 1.2K citations · Full text

Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma

Rachel G. Liao, Joonil Jung, Jeremy H. Tchaicha et al. · Cancer Research · 2013 · 167 citations · Full text

Family Members, Fgfr Inhibitors, Medicine +14

Identification and characterization of an alternative cancer-derived PD-L1 splice variant

Nadia B. Hassounah, Venkat S. Malladi, Yi Huang et al. · Cancer Immunology Immunotherapy · 2018 · 82 citations

Oncology, Oncogenic Agent, Medicine +8

Characterization of DDR2 Inhibitors for the Treatment of <i>DDR2</i> Mutated Nonsmall Cell Lung Cancer

Hideki Terai, Li Tan, Ellen M. Beauchamp et al. · ACS Chemical Biology · 2015 · 70 citations · Full text

Chemoprevention Strategy, Pathology, Tumor Biology +19

Acquired Resistance to Dasatinib in Lung Cancer Cell Lines Conferred by <i>DDR2</i> Gatekeeper Mutation and <i>NF1</i> Loss

Ellen M. Beauchamp, Brittany A. Woods, Austin Dulak et al. · Molecular Cancer Therapeutics · 2013 · 56 citations · Full text